Wolverine Trading, LLC Ptc Therapeutics, Inc. Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $187,327 - $239,853	4,909 New	4,909 $240,000
Q4 2019 Feb 12, 2020	SELL	$32.22 - $50.07 $106,261 - $165,130	-3,298 Reduced 18.67%	14,367 $683,000
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $185,536 - $264,260	-5,486 Reduced 23.7%	17,665 $612,000
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $379,158 - $533,036	13,498 Added 139.83%	23,151 $871,000
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $2,028 - $3,162	68 Added 0.71%	9,653 $309,000
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $36,273 - $51,113	1,070 Added 12.57%	9,585 $450,000
Q1 2018 May 15, 2018	SELL	$17.46 - $32.59 $176,555 - $329,550	-10,112 Reduced 54.29%	8,515 $230,000
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $282,012 - $389,118	18,627	18,627 $311,000

232

78.1M

144K

54.8K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.54B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.